Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Saroglitazar for the treatment of hepatocellular carcinoma

Saroglitazar for the treatment of hepatocellular carcinoma

US Patent 12201609 · Granted Jan 21, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment for primary biliary cholangitis2024
Treatment for primary biliary cholangitis2024
Treatment for primary biliary cholangitis2024
Treatment for primary biliary cholangitis2024
Trial stimulation systems2023
Trial stimulation systems2022
Treatment for primary biliary cholangitis2022
Treatment for primary biliary cholangitis2022
Trial stimulation systems2022
Peptide based PCSK9 vaccine2022
Peptide based PCSK9 vaccine2022
Smart commissioning for first responders in incident command system2020